{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:44:29Z","timestamp":1770291869359,"version":"3.49.0"},"reference-count":43,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2014.00236","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T15:57:12Z","timestamp":1406044632000},"source":"Crossref","is-referenced-by-count":14,"title":["ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis"],"prefix":"10.3389","volume":"5","author":[{"given":"Athanassios","family":"Kotsinas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Papanagnou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Trigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Kostourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis G.","family":"Gorgoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","article-title":"Atm-deficient mice: a paradigm of ataxia telangiectasia.","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1242\/dev.125.20.4007","article-title":"Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I.","volume":"125","author":"Barlow","year":"1998","journal-title":"Development"},{"key":"B3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch.","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4024","article-title":"ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.","volume":"227","author":"Busch","year":"2012","journal-title":"J. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrg911","article-title":"Mouse models of male infertility.","volume":"3","author":"Cooke","year":"2002","journal-title":"Nat. Rev. Genet."},{"issue":"e1002157","key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002157","article-title":"Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.","volume":"7","author":"Churchman","year":"2011","journal-title":"PLoS Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1183\/09059180.00008913","article-title":"Therapeutic options targeting angiogenesis in nonsmall cell lung cancer.","volume":"23","author":"Crin\u00c3\u00b2","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/ijc.25510","article-title":"Loss of p14ARF confers resistance to heat shock- and oxidative stress-mediated cell death by upregulating \u00ce\u00b2-catenin.","volume":"128","author":"Damalas","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1101\/gad.12.15.2434","article-title":"E1A signaling to p53 involves the p19ARF tumor suppressor.","volume":"12","author":"de Stanchina","year":"1998","journal-title":"Genes Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jnci\/djr511","article-title":"Targeted therapies for renal cell carcinoma: review of adverse event management strategies.","volume":"104","author":"Eisen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13084","DOI":"10.1073\/pnas.93.23.13084","article-title":"Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.","volume":"93","author":"Elson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"28421","DOI":"10.1074\/jbc.M102847200","article-title":"The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription.","volume":"276","author":"Fatyol","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1242\/dev.033548","article-title":"Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development.","volume":"136","author":"Freeman-Anderson","year":"2009","journal-title":"Development"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","article-title":"Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.","volume":"8","author":"Golding","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jacc.2010.01.026","article-title":"p19ARF deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.","volume":"55","author":"Gonz\u00c3\u00a1lez-Navarro","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1073\/pnas.0902310106","article-title":"Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.","volume":"106","author":"Gromley","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4161\/epi.5.4.11518","article-title":"DNA double strand break repair, chromosome synapsis and transcriptional silencing in meiosis.","volume":"5","author":"Inagaki","year":"2010","journal-title":"Epigenetics"},{"key":"B19","first-page":"2217","article-title":"Tumor spectrum in ARF-deficient mice.","volume":"59","author":"Kamijo","year":"1999","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1158\/0008-5472.CAN-10-0368","article-title":"ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA.","volume":"70","author":"Kawagishi","year":"2010","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nm.2881","article-title":"The dark side of the oxidative force in angiogenesis.","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.4161\/cc.28654","article-title":"MKK7 and ARF: new players in the DNA damage response scenery.","volume":"13","author":"Kotsinas","year":"2014","journal-title":"Cell Cycle"},{"key":"B23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/156652412800792633","article-title":"The tumor suppressor gene ARF as a sensor of oxidative stress.","volume":"12","author":"Liontos","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","article-title":"Tumor suppression by Ink4a-Arf: progress and puzzles.","volume":"13","author":"Lowe","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.052484199","article-title":"The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.","volume":"99","author":"McKeller","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/25870","article-title":"p19ARF links the tumour suppressor p53 to Ras.","volume":"395","author":"Palmero","year":"1999","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ygyno.2010.02.021","article-title":"Bevacizumab toxicities and their management in ovarian cancer.","volume":"117","author":"Randall","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2174\/092986707781058869","article-title":"Therapeutic targets in the ARF tumor suppressor pathway.","volume":"14","author":"Saporita","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc1954","article-title":"Divorcing ARF and p53: an unsettled case.","volume":"6","author":"Sherr","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/sj.emboj.7600751","article-title":"Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.","volume":"24","author":"Silva","year":"2005","journal-title":"EMBO J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1097-2765(03)00057-1","article-title":"Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.","volume":"11","author":"Sugimoto","year":"2003","journal-title":"Mol. Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1073\/pnas.0502978102","article-title":"Sumoylation induced by the Arf tumor suppressor: a p53-independent function.","volume":"102","author":"Tago","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.stem.2007.10.023","article-title":"Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest.","volume":"2","author":"Takubo","year":"2008","journal-title":"Cell Stem Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4161\/cc.4.10.2109","article-title":"The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf-\/- mice.","volume":"4","author":"Thornton","year":"2005","journal-title":"Cell Cycle"},{"issue":"568783","key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/568783","article-title":"Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.","volume":"2012","author":"Trav\u00c3\u00a9s","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.ejca.2005.08.005","article-title":"Involvement of E2F transcription factor family in cancer.","volume":"41","author":"Tsantoulis","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"e12454","key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012454","article-title":"Loss of p19Arf facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.","volume":"5","author":"Ulanet","year":"2010","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ncb2795","article-title":"Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.","volume":"15","author":"Velimezi","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1101\/gad.827300","article-title":"p53-independent functions of the p19ARF tumor suppressor.","volume":"14","author":"Weber","year":"2000","journal-title":"Genes Dev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1101\/gad.10.19.2411","article-title":"Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.","volume":"10","author":"Xu","year":"1996","journal-title":"Genes Dev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1091\/mbc.E03-11-0785","article-title":"p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.","volume":"15","author":"Yi","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","article-title":"Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.","volume":"12","author":"Zindy","year":"1998","journal-title":"Genes Dev."}],"container-title":["Frontiers in Genetics"],"original-title":[],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T23:28:31Z","timestamp":1649719711000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fgene.2014.00236\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3389\/fgene.2014.00236","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]}}}